Table 1.
Characteristic | Category | Dalantercept | |
---|---|---|---|
n | % | ||
Age Group | 40–49 | 1 | 3.6 |
50–59 | 9 | 32.1 | |
60–69 | 13 | 46.4 | |
70–79 | 5 | 17.9 | |
Ethnicity | Hispanic or Latino | 2 | 7.1 |
Non-Hispanic | 23 | 82.1 | |
Unknown/Not specified | 3 | 10.7 | |
Race | White | 24 | 85.7 |
Black/African American | 3 | 10.7 | |
Unspecified | 1 | 3.6 | |
Performance Status | 0 | 20 | 71.4 |
1 | 8 | 28.6 | |
Cell Type/Grade | Endometrioid, grade 1 | 4 | 14.3 |
Endometrioid, grade 2 | 6 | 21.4 | |
Serous | 15 | 53.6 | |
Clear Cell | 2 | 7.1 | |
Mixed Epithelial | 1 | 3.6 | |
Prior Chemotherapy | 1 Prior Regimen | 23 | 82.1 |
2 Prior Regimens | 5 | 17.9 | |
Prior Radiation | No | 10 | 35.7 |
Yes | 18 | 64.3 | |
Prior Hormonal | No | 25 | 89.3 |
Therapy | Yes | 3 | 10.7 |
Prior Surgery | Yes | 28 | 100.0 |